JPMorgan Chase & Co’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $264M | Sell |
|
|||||
|
2025
Q1 | $338M | Sell |
|
|||||
|
2024
Q4 | $344M | Sell |
|
|||||
|
2024
Q3 | $415M | Buy |
|
|||||
|
2024
Q2 | $333M | Buy |
|
|||||
|
2024
Q1 | $270M | Buy |
|
|||||
|
2023
Q4 | $239M | Buy |
|
|||||
|
2023
Q3 | $139M | Sell |
|
|||||
|
2023
Q2 | $149M | Sell |
|
|||||
|
2023
Q1 | $185M | Sell |
|
|||||
|
2022
Q4 | $226M | Buy |
|
|||||
|
2022
Q3 | $98.3M | Buy |
|
|||||
|
2022
Q2 | $55.1M | Buy |
|
|||||
|
2022
Q1 | $44M | Buy |
|
|||||
|
2021
Q4 | $23.3M | Sell |
|
|||||
|
2021
Q3 | $91M | Sell |
|
|||||
|
2021
Q2 | $98.8M | Sell |
|
|||||
|
2021
Q1 | $101M | Buy |
|
|||||
|
2020
Q4 | $73.9M | Buy |
|
|||||
|
2020
Q3 | $16.6M | Buy |
|
|||||
|
2020
Q2 | $13.8M | Sell |
|
|||||
|
2020
Q1 | $22.3M | Sell |
|
|||||
|
2019
Q4 | $32.7M | Buy |
|
|||||
|
2019
Q3 | $10.7M | Sell |
|
|||||
|
2019
Q2 | $11.7M | Sell |
|
|||||
|
2019
Q1 | $47.1M | Buy |
|
|||||
|
2018
Q4 | $35.6M | Buy |
|
|||||
|
2018
Q3 | $7.93M | Buy |
|
|||||
|
2018
Q2 | $5.11M | Sell |
|
|||||
|
2018
Q1 | $6.41M | Buy |
|
|||||
|
2017
Q4 | $5.96M | Buy |
|
|||||
|
2017
Q3 | $4.64M | Sell |
|
|||||
|
2017
Q2 | $29.6M | Buy |
|
|||||
|
2017
Q1 | $11.6M | Sell |
|
|||||
|
2016
Q4 | $52.2M | Buy |
|
|||||
|
2016
Q3 | $32.7M | Sell |
|
|||||
|
2016
Q2 | $69.3M | Sell |
|
|||||
|
2016
Q1 | $65.5M | Buy |
|
|||||
|
2015
Q4 | $75.6M | Sell |
|
|||||
|
2015
Q3 | $73.6M | Buy |
|
|||||
|
2015
Q2 | $53.4M | Sell |
|
|||||
|
2015
Q1 | $73.2M | Buy |
|
|||||
|
2014
Q4 | $68M | Sell |
|
|||||
|
2014
Q3 | $142M | Buy |
|
|||||
|
2014
Q2 | $122M | Buy |
|
|||||
|
2014
Q1 | $59.6M | Buy |
|
|||||
|
2013
Q4 | $49M | Buy |
|
|||||
|
2013
Q3 | $31.9M | Buy |
|
|||||
|
2013
Q2 | $28.1M | Buy |
|